Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Maria Teresa Van Lint
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Disorders
Concepts & Ideas
Phenomena
Chemicals & Drugs
Living Beings
Sign-in to see full Profile
Network (preview)
112
Bacigalupo, Andrea
58
Frassoni, Francesco
54
Gualandi, Francesca
47
Lamparelli, Teresa
44
Occhini, Domenico
32
Bregante, Stefania
27
Piaggio, Giovanna
26
Marmont, Alberto
22
Raiola, Anna Maria
21
Bruno, Benedetto
18
Mordini, Nicola
18
Vitale, Vito
16
Tedone, Elisabetta
16
Dominietto, Alida
15
Berisso, Giovanni
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Maria Teresa Van Lint (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Capello E; Vuolo L; Gualandi F; Van Lint M T; Roccatagliata L; Bonzano L; Pardini M; Uccelli A; Mancardi Gianluigi
Autologous haematopoietic stem-cell transplantation in multiple sclerosis: benefits and risks.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2009;30 Suppl 2():S175-7.
-
2009: Mikulska M; Raiola A M; Bruno B; Furfaro E; Van Lint M T; Bregante S; Ibatici A; Del Bono V; Bacigalupo A; Viscoli C
Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients.
Bone marrow transplantation 2009;44(6):361-70.
-
2008: Alessandrino Emilio Paolo; Della Porta Matteo Giovanni; Bacigalupo Andrea; Van Lint Maria Teresa; Falda Michele; Onida Francesco; Bernardi Massimo; Iori Anna Paola; Rambaldi Alessandro; Cerretti Raffaella; Marenco Paola; Pioltelli Pietro; Malcovati Luca; Pascutto Cristiana; Oneto Rosi; Fanin Renato; Bosi Alberto;
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
Blood 2008;112(3):895-902.
-
2008: Viollier R; Socié G; Tichelli A; Bacigalupo A; Korthof E T; Marsh J; Cornish J; Ljungman P; Oneto R; Békássy A N; Fuehrer M; Maury S; Schrezenmeier H; van Lint M T; Wojcik D; Locasciulli A; Passweg J R
Recent improvement in outcome of unrelated donor transplantation for aplastic anemia.
Bone marrow transplantation 2008;41(1):45-50.
-
2007: Bacigalupo A; Raiola A M; Lamparelli T; Gualandi F; Occhini D; Bregante S; Ibatici A; di Grazia C; Dominietto A; Bruno B; Van Lint M T; Frassoni F
Thiotepa-based reduced intensity conditioning regimen: a 10 year follow up.
Bone marrow transplantation 2007;40(11):1091-3.
-
2007: Gualandi F; Bruno B; Van Lint M T; Luchetti S; Uccelli A; Capello E; Mancardi G L; Bacigalupo A; Marmont A
Autologous stem cell transplantation for severe autoimmune diseases: a 10-year experience.
Annals of the New York Academy of Sciences 2007;1110():455-64.
-
2007: Vicente D; Lamparelli T; Gualandi F; Occhini D; Raiola A M; Ibatici A; Van Lint M T; Gobbi M; Miglino M; Clavio M; Risso M; Frassoni F; Bacigalupo A
Improved outcome in young adults with de novo acute myeloid leukemia in first remission, undergoing an allogeneic bone marrow transplant.
Bone marrow transplantation 2007;40(4):349-54.
-
2007: Zaja F; Bacigalupo A; Patriarca F; Stanzani M; Van Lint M T; Filì C; Scimè R; Milone G; Falda M; Vener C; Laszlo D; Alessandrino P E; Narni F; Sica S; Olivieri A; Sperotto A; Bosi A; Bonifazi F; Fanin R;
Treatment of refractory chronic GVHD with rituximab: a GITMO study.
Bone marrow transplantation 2007;40(3):273-7.
-
2007: Clavio Marino; Vignolo Luana; Albarello Alessandra; Varaldo Riccardo; Pierri Ivana; Catania Gioacchino; Balocco Manuela; Michelis Gianluca; Miglino Maurizio; Manna Annunziata; Balleari Enrico; Carella A Michele; Sessarego Mario; Van Lint Maria Teresa; Bacigalupo Andrea; Gobbi Marco
Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia: results of a prospective, pilot, multi-centre trial and comparison with a historical cohort of patients.
British journal of haematology 2007;138(2):186-95.
-
2007: Cappellano Paola; Viscoli Claudio; Bruzzi Paolo; Van Lint Maria Teresa; Pereira Carlos Alberto Pires; Bacigalupo Andrea
Epidemiology and risk factors for bloodstream infections after allogeneic hematopoietic stem cell transplantion.
The new microbiologica : official journal of the Italian Society for Medical, Odontoiatric, and Clinical Microbiology (SIMMOC) 2007;30(2):89-99.
-
2007: Bacigalupo A; Lamparelli T; Gualandi F; Occhini D; Bregante S; Raiola A M; Ibatici A; di Grazia C; Dominietto A; Piaggio G; Podesta M; Bruno B; Lombardi A; Frassoni F; Viscoli C; Sacchi N; Van Lint M T
Allogeneic hemopoietic stem cell transplants for patients with relapsed acute leukemia: long-term outcome.
Bone marrow transplantation 2007;39(6):341-6.
-
2006: Marmont A M; Dominietto A; Gualandi F; Piaggio G; van Lint M T; Bacigalupo A
Pure white cell aplasia (PWCA) relapsing after allogeneic BMT and successfully treated with nine DLIs.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(9):987-9.
-
2006: Larocca Alessandra; Piaggio Giovanna; Podestà Marina; Pitto Anna; Bruno Barbara; Di Grazia Carmen; Gualandi Francesca; Occhini Domenico; Raiola Anna Maria; Dominietto Alida; Bregante Stefania; Lamparelli Teresa; Tedone Elisabetta; Oneto Rosi; Frassoni Francesco; Van Lint Maria Teresa; Pogliani Enrico; Bacigalupo Andrea
Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation.
Haematologica 2006;91(7):935-40.
-
2006: Vicente D; Podestà M; Pitto A; Pozzi S; Lucchetti S; Lamparelli T; Tedone E; Ibatici A; Figari O; Frassoni F; Van Lint M T; Piaggio G; Sacchi N; Bacigalupo A
Progenitor cells trapped in marrow filters can reduce GvHD and transplant mortality.
Bone marrow transplantation 2006;38(2):111-7.
-
2006: Bacigalupo Andrea; Lamparelli Teresa; Barisione Giovanni; Bruzzi Paolo; Guidi Stefano; Alessandrino Paolo Emilio; di Bartolomeo Paolo; Oneto Rosi; Bruno Barbara; Sacchi Nicoletta; van Lint Maria Teresa; Bosi Alberto;
Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(5):560-5.
-
2006: Van Lint Maria Teresa; Milone Giuseppe; Leotta Salvatore; Uderzo Cornelio; Scimè Rosanna; Dallorso Sandro; Locasciulli Anna; Guidi Stefano; Mordini Nicola; Sica Simona; Cudillo Laura; Fagioli Franca; Selleri Carmine; Bruno Barbara; Arcese William; Bacigalupo Andrea
Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin.
Blood 2006;107(10):4177-81.
-
2006: Marmont A M; Gualandi F; van Lint M T; Guastoni C; Bacigalupo A
Long term complete remission of severe nephrotic syndrome secondary to diffuse global (IV-G) lupus nephritis following autologous, haematopoietic peripheral stem (CD34+) cell transplantation.
Lupus 2006;15(1):44-6.
-
2005: Bacigalupo Andrea; Valle Marisa; Podestà Marina; Pitto Anna; Zocchi Elena; De Flora Antonio; Pozzi Sara; Luchetti Silvia; Frassoni Francesco; Van Lint Maria Teresa; Piaggio Giovanna
T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia.
Experimental hematology 2005;33(7):819-27.
-
2004: Bacigalupo Andrea; Sormani Maria Pia; Lamparelli Teresa; Gualandi Francesca; Occhini Domenico; Bregante Stefania; Raiola Anna Maria; di Grazia Carmen; Dominietto Alida; Tedone Elisabetta; Piaggio Giovanna; Podesta Marina; Bruno Barbara; Oneto Rosi; Lombardi Anna; Frassoni Francesco; Rolla Davide; Rollandi Gianandrea; Viscoli Claudio; Ferro Carlo; Garbarino Lucia; Van Lint Maria Teresa
Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation.
Haematologica 2004;89(10):1238-47.
-
2004: Viscoli Claudio; Machetti Marco; Cappellano Paola; Bucci Barbara; Bruzzi Paolo; Van Lint Maria Teresa; Bacigalupo Andrea
False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(6):913-6.
-
2003: Spinelli Simonetta; Chiodi Sandra; Costantini Sergio; Van Lint Maria Teresa; Raiola Anna Maria; Ravera Gian Battista; Bacigalupo Andrea
Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation.
Haematologica 2003;88(10):1163-8.
-
2003: Sormani M P; Oneto R; Bruno B; Fiorone M; Lamparelli T; Gualandi F; Raiola A M; Dominietto A; Van Lint M T; Frassoni F; Bruzzi P; Bacigalupo A
A revised day +7 predictive score for transplant-related mortality: serum cholinesterase, total protein, blood urea nitrogen, gamma glutamyl transferase, donor type and cell dose.
Bone marrow transplantation 2003;32(2):205-11.
-
2003: Raiola A M; Van Lint M T; Valbonesi M; Lamparelli T; Gualandi F; Occhini D; Bregante S; di Grazia C; Dominietto A; Soracco M; Romagnani C; Vassallo F; Casini M; Bruno B; Frassoni F; Bacigalupo A
Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusions.
Bone marrow transplantation 2003;31(8):687-93.
-
2003: Marmont A M; Gualandi F; Van Lint M T; Bacigalupo A
Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect.
Bone marrow transplantation 2003;31(5):399-402.
-
2002: Corvò R; Lamparelli T; Bruno B; Barra S; Van Lint M T; Vitale V; Bacigalupo A
Low-dose fractionated total body irradiation (TBI) adversely affects prognosis of patients with leukemia receiving an HLA-matched allogeneic bone marrow transplant from an unrelated donor (UD-BMT).
Bone marrow transplantation 2002;30(11):717-23.
-
2002: Dominietto Alida; Lamparelli Teresa; Raiola Anna Maria; Van Lint Maria Teresa; Gualandi Francesca; Berisso Giovanni; Bregante Stefania; Di Grazia Carmen; Soracco Monica; Pitto Anna; Frassoni Francesco; Bacigalupo Andrea
Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantation.
Blood 2002;100(12):3930-4.
-
2002: Graziani Francesco; Van Lint Maria Teresa; Dominietto Alida; Raiola Anna Maria; Di Grazia Carmela; Lamparelli Teresa; Gualandi Francesca; Bregante Stefania; Fiorone Merilù; Bruno Barbara; Bacigalupo Andrea
Treatment of acute graft versus host disease with low dose-alternate day anti-thymocyte globulin.
Haematologica 2002;87(9):973-8.
-
2002: Balleari Enrico; Garre Simona; Van Lint Maria Teresa; Spinelli Simonetta; Chiodi Sandra; Repetto Enrico; Massa Giulio; Bacigalupo Andrea; Ghio Riccardo
Hormone replacement therapy and chronic graft-versus-host disease activity in women treated with bone marrow transplantation for hematologic malignancies.
Annals of the New York Academy of Sciences 2002;966():187-92.
-
2002: Viscoli Claudio; Machetti Marco; Gazzola Paola; De Maria Andrea; Paola Dimitri; Van Lint Maria Teresa; Gualandi Francesca; Truini Mauro; Bacigalupo Andrea
Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis.
Journal of clinical microbiology 2002;40(4):1496-9.
-
2002: Bacigalupo A; Lamparelli T; Gualandi F; Bregante S; Raiola A M; Di Grazia C; Dominietto A; Bruno B; Galbusera V; Frassoni F; Podesta M; Tedone E; Occhini D; Van Lint M T
Prophylactic antithymocyte globulin reduces the risk of chronic graft-versus-host disease in alternative-donor bone marrow transplants.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(12):656-61.
-
2001: Bacigalupo A; Oneto R; Lamparelli T; Gualandi F; Bregante S; Raiola A M; Di Grazia C; Dominietto A; Romagnani C; Bruno B; Van Lint M T; Frassoni F
Pre-emptive therapy of acute graft-versus-host disease: a pilot study with antithymocyte globulin (ATG).
Bone marrow transplantation 2001;28(12):1093-6.
-
2001: Bacigalupo A; Oneto R; Bruno B; Lamparelli T; Gualandi F; Bregante S; Raiola A M; Di Grazia C; Dominietto A; Lombardi A; Frassoni F; Van Lint M T
Serum cholinesterase is an early and sensitive marker of graft-versus host-disease (GVHD) and transplant-related mortality (TRM).
Bone marrow transplantation 2001;28(11):1041-5.
-
2001: Bicigalupo A; Lamparelli T; Gualandi F; Bregante S; Raiola A; di Grazia C; Dominietto A; Romagnani C; Occhini D; Frassoni F; van Lint M T
Increased risk of leukemia relapse with high dose cyclosporine after allogeneic marrow transplantation for acute leukemia: 10 year follow-up of a randomized study.
Blood 2001;98(10):3174-5.
-
2001: Bacigalupo A; Lamparelli T; Bruzzi P; Guidi S; Alessandrino P E; di Bartolomeo P; Oneto R; Bruno B; Barbanti M; Sacchi N; Van Lint M T; Bosi A
Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).
Blood 2001;98(10):2942-7.
-
2001: di Grazia C; Raiola A M; Van Lint M T; Lamparelli T; Gualandi F; Berisso G; Bregante S; Dominietto A; Mordini N; Bruno B; Frassoni F; Bacigalupo A
Conventional hematopoietic stem cell transplants from identical or alternative donors are feasible in recipients relapsing after an autograft.
Haematologica 2001;86(6):646-51.
-
2001: Dominietto A; Raiola A M; van Lint M T; Lamparelli T; Gualandi F; Berisso G; Bregante S; Frassoni F; Casarino L; Verdiani S; Bacigalupo A
Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose.
British journal of haematology 2001;112(1):219-27.
-
2000: Lamparelli T; van Lint M T; Gualandi F; Raiola A M; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Bregante S; Berisso G; Dominietto A; Di Grazia C; Bruno B; Sessarego M; Casarino L; Verdiani S; Bacigalupo A
Alternative donor transplants for patients with advanced hematologic malignancies, conditioned with thiotepa, cyclophosphamide and antithymocyte globulin.
Bone marrow transplantation 2000;26(12):1305-11.
-
2000: Machetti M; Zotti M; Veroni L; Mordini N; Van Lint M T; Bacigalupo A; Paola D; Viscoli C
Antigen detection in the diagnosis and management of a patient with probable cerebral aspergillosis treated with voriconazole.
Transplant infectious disease : an official journal of the Transplantation Society 2000;2(3):140-4.
-
2000: Valbonesi M; De Luigi M C; Lercari G; Florio G; Bruni R; Van Lint M T; Occhini D
Acute intravascular hemolysis in two patients transfused with dry-platelet units obtained from the same ABO incompatible donor.
The International journal of artificial organs 2000;23(9):642-6.
-
2000: Chiodi S; Spinelli S; Ravera G; Petti A R; Van Lint M T; Lamparelli T; Gualandi F; Occhini D; Mordini N; Berisso G; Bregante S; Frassoni F; Bacigalupo A
Quality of life in 244 recipients of allogeneic bone marrow transplantation.
British journal of haematology 2000;110(3):614-9.
-
2000: Locatelli F; Bruno B; Zecca M; Van-Lint M T; McCann S; Arcese W; Dallorso S; Di Bartolomeo P; Fagioli F; Locasciulli A; Lawler M; Bacigalupo A
Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial.
Blood 2000;96(5):1690-7.
-
2000: Bregante S; Bertilson S; Tedone E; Van Lint M T; Trespi G; Mordini N; Berisso G; Gualandi F; Lamparelli T; Figari O; Benvenuto F; Raiola A M; Bacigalupo A
Foscarnet prophylaxis of cytomegalovirus infections in patients undergoing allogeneic bone marrow transplantation (BMT): a dose-finding study.
Bone marrow transplantation 2000;26(1):23-9.
-
2000: Raiola A M; Van Lint M T; Lamparelli T; Gualandi F; Mordini N; Berisso G; Bregante S; Frassoni F; Sessarego M; Fugazza G; Di Stefano F; Pitto A; Bacigalupo A
Reduced intensity thiotepa-cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of age.
British journal of haematology 2000;109(4):716-21.
-
2000: Bacigalupo A; Brand R; Oneto R; Bruno B; Socié G; Passweg J; Locasciulli A; Van Lint M T; Tichelli A; McCann S; Marsh J; Ljungman P; Hows J; Marin P; Schrezenmeier H
Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience.
Seminars in hematology 2000;37(1):69-80.
-
2000: Bacigalupo A; Vitale V; Corvò R; Barra S; Lamparelli T; Gualandi F; Mordini N; Berisso G; Bregante S; Raiola A M; Van Lint M T; Frassoni F
The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantation.
British journal of haematology 2000;108(1):99-104.
-
2000: Raiola A M; Van Lint M T; Lamparelli T; Gualandi F; Benvenuto F; Figari O; Mordini N; Berisso G; Bregante S; Frassoni F; Bacigalupo A
Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria.
Haematologica 2000;85(1):59-62.
-
2000: Bacigalupo A; Oneto R; Bruno B; Socié G; Passweg J; Locasciulli A; Van Lint M T; Tichelli A; McCann S; Marsh J; Ljungman P; Hows J; Marin P; Schrezenmeier H
Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the European Group for Blood and Marrow transplantation. On behalf of the Working Party on Severe Aplastic Anemia of the European Group for Blood and Marrow Transplantation.
Acta haematologica 2000;103(1):19-25.
-
1999: Piaggio G; Podestà M; Pitto A; Sessarego M; Figari O; Fugazza G; Benvenuto F; Bruno B; Van Lint M T; Truini M; Frassoni F; Bacigalupo A
Coexistence of normal and clonal haemopoiesis in aplastic anaemia patients treated with immunosuppressive therapy.
British journal of haematology 1999;107(3):505-11.
-
1999: Bacigalupo A; Lamparelli T; Barbanti M; Sacchi N; Battista Ferrara G; Pozzi S; Bregante S; Mordini N; Vitale V; Van Lint M T
Improved results in marrow transplantation from unrelated donors. Genoa BMT Group.
Haematologica 1999;84 Suppl EHA-4():50-2.
-
1999: Berisso G A; van Lint M T; Bacigalupo A; Marmont A M
Adoptive autoimmune hyperthyroidism following allogeneic stem cell transplantation from an HLA-identical sibling with Graves' disease.
Bone marrow transplantation 1999;23(10):1091-2.
-
1999: Messori A; Bosi A; Bacci S; Laszlo D; Trippoli S; Locatelli F; Van Lint M T; Di Bartolomeo P; Amici A
Retrospective survival analysis and cost-effectiveness evaluation of second allogeneic bone marrow transplantation in patients with acute leukemia. Gruppo Italiano Trapianto di Midollo Osseo.
Bone marrow transplantation 1999;23(5):489-95.
-
1999: Corvò R; Paoli G; Barra S; Bacigalupo A; Van Lint M T; Franzone P; Frassoni F; Scarpati D; Bacigalupo A; Vitale V
Total body irradiation correlates with chronic graft versus host disease and affects prognosis of patients with acute lymphoblastic leukemia receiving an HLA identical allogeneic bone marrow transplant.
International journal of radiation oncology, biology, physics 1999;43(3):497-503.
-
1999: Corradini P; Voena C; Tarella C; Astolfi M; Ladetto M; Palumbo A; Van Lint M T; Bacigalupo A; Santoro A; Musso M; Majolino I; Boccadoro M; Pileri A
Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):208-15.
-
1998: Carella A M; Lerma E; Dejana A; Corsetti M T; Celesti L; Bruni R; Benvenuto F; Figari O; Parodi C; Carlier P; Florio G; Lercari G; Valbonesi M; Casarino L; De Stefano F; Geniram A; Venturino M; Tedeschi L; Palmieri G; Piaggio G; Podestà M; Frassoni F; Van Lint M T; Marmont A M; Bacigalupo A
Engraftment of HLA-matched sibling hematopoietic stem cells after immunosuppressive conditioning regimen in patients with hematologic neoplasias.
Haematologica 1998;83(10):904-9.
-
1998: Zikos P; Van Lint M T; Lamparelli T; Gualandi F; Occhini D; Bregante S; Berisso G; Mordini N; Incagliato M; Fugazza G; Sessarego M; Bacigalupo A
Allogeneic hemopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: favorable impact of chronic graft-versus-host disease on survival and relapse.
Haematologica 1998;83(10):896-903.
-
1998: Marmont A M; van Lint M T; Occhini D; Lamparelli T; Bacigalupo A
Failure of autologous stem cell transplantation in refractory thrombocytopenic purpura.
Bone marrow transplantation 1998;22(8):827-8.
-
1998: Van Lint M T; Uderzo C; Locasciulli A; Majolino I; Scimé R; Locatelli F; Giorgiani G; Arcese W; Iori A P; Falda M; Bosi A; Miniero R; Alessandrino P; Dini G; Rotoli B; Bacigalupo A
Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation.
Blood 1998;92(7):2288-93.
-
1998: Moretti S; Zikos P; Van Lint M T; Tedone E; Occhini D; Gualandi F; Lamparelli T; Mordini N; Berisso G; Bregante S; Bruno B; Bacigalupo A
Forscarnet vs ganciclovir for cytomegalovirus (CMV) antigenemia after allogeneic hemopoietic stem cell transplantation (HSCT): a randomised study.
Bone marrow transplantation 1998;22(2):175-80.
-
1998: Machetti M; Feasi M; Mordini N; Van Lint M T; Bacigalupo A; Latgé J P; Sarfati J; Viscoli C
Comparison of an enzyme immunoassay and a latex agglutination system for the diagnosis of invasive aspergillosis in bone marrow transplant recipients.
Bone marrow transplantation 1998;21(9):917-21.
-
1998: Bacigalupo A; Zikos P; Van Lint M T; Valbonesi M; Lamparelli T; Gualandi F; Occhini D; Mordini N; Bregante S; Berisso G; Vitale V; Sessarego M; Marmont A M
Allogeneic bone marrow or peripheral blood cell transplants in adults with hematologic malignancies: a single-center experience.
Experimental hematology 1998;26(5):409-14.
-
1998: Zikos P; Van Lint M T; Frassoni F; Lamparelli T; Gualandi F; Occhini D; Mordini N; Berisso G; Bregante S; De Stefano F; Soracco M; Vitale V; Bacigalupo A
Low transplant mortality in allogeneic bone marrow transplantation for acute myeloid leukemia: a randomized study of low-dose cyclosporin versus low-dose cyclosporin and low-dose methotrexate.
Blood 1998;91(9):3503-8.
-
1998: Zikos P; Van Lint M T; Lamparelli T; Gualandi F; Occhini D; Mordini N; Berisso G; Bregante S; Bacigalupo A
A randomized trial of high dose polyvalent intravenous immunoglobulin (HDIgG) vs. Cytomegalovirus (CMV) hyperimmune IgG in allogeneic hemopoietic stem cell transplants (HSCT).
Haematologica 1998;83(2):132-7.
-
1997: Lamparelli T; Van Lint M T; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara G B; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
Bone marrow transplantation 1997;20(12):1057-62.
-
1997: Bacigalupo A; Mordini N; Pitto A; Piaggio G; Podestà M; Benvenuto F; van Lint M T; Valbonesi M; Lercari G; Carlier P; Lamparelli T; Gualandi F; Occhini D; Bregante S; Figari O; Soracco M; Vassallo F; De Stefano G
Transplantation of HLA-mismatched CD34+ selected cells in patients with advanced malignancies: severe immunodeficiency and related complications.
British journal of haematology 1997;98(3):760-6.
-
1997: Bacigalupo A; Soracco M; Vassallo F; Abate M; Van Lint M T; Gualandi F; Lamparelli T; Occhini D; Mordini N; Bregante S; Figari O; Benvenuto F; Sessarego M; Fugazza G; Carlier P; Valbonesi M
Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation.
Bone marrow transplantation 1997;19(9):927-32.
-
1997: Bacigalupo A; Piaggio G; Podestà M; Tong J; Pitto A; Figari O; Benvenuto F; Vassallo F; Tedone E; Grassia L; Van Lint M T; Gualandi F; Hoffman R
Early hemopoietic progenitors in the peripheral blood of patients with severe aplastic anemia (SAA) after treatment with antilymphocyte globulin (ALG), cyclosporin-A and G-CSF.
Haematologica 1997;82(2):133-7.
-
1997: Bosi A; Bacci S; Miniero R; Locatelli F; Laszlo D; Longo G; Busca A; Van Lint M T; Di Bartolomeo P; Amici A
Second allogeneic bone marrow transplantation in acute leukemia: a multicenter study from the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11(3):420-4.
-
1997: Marmont A M; van Lint M T; Gualandi F; Bacigalupo A
Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration.
Lupus 1997;6(6):545-8.
-
1996: Bacigalupo A; Bregante S; Tedone E; Isaza A; Van Lint M T; Moro F; Trespi G; Occhini D; Gualandi F; Lamparelli T; Marmont A M
Combined foscarnet -ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation (Hsct).
Bone marrow transplantation 1996;18 Suppl 2():110-4.
-
1996: Mikhailova N; Sessarego M; Fugazza G; Caimo A; De Filippi S; van Lint M T; Bregante S; Valeriani A; Mordini N; Lamparelli T; Gualandi F; Occhini D; Bacigalupo A
Cytogenetic abnormalities in patients with severe aplastic anemia.
Haematologica 1996;81(5):418-22.
-
1996: Bacigalupo A; Bregante S; Tedone E; Isaza A; Van Lint M T; Trespi G; Occhini D; Gualandi F; Lamparelli T; Marmont A M
Combined foscarnet-ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation.
Transplantation 1996;62(3):376-80.
-
1996: Bacigalupo A; Van Lint M T; Valbonesi M; Lercari G; Carlier P; Lamparelli T; Gualandi F; Occhini D; Bregante S; Valeriani A; Piaggio G; Pitto A; Benvenuto F; Figari O; De Stefano G; Caimo A; Sessarego M
Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia.
Blood 1996;88(1):353-7.
-
1995: Bacigalupo A; Tedone E; Isaza A; Soracco M; Van Lint M T; Sanna A; Frassoni F; Occhini D; Gualandi F; Lamparelli T
CMV-antigenemia after allogeneic bone marrow transplantation: correlation of CMV-antigen positive cell numbers with transplant-related mortality.
Bone marrow transplantation 1995;16(1):155-61.
-
1994: Bacigalupo A; Tedone E; Van Lint M T; Trespi G; Lonngren M; Sanna M A; Moro F; Frassoni F; Occhini D; Gualandi F
CMV prophylaxis with foscarnet in allogeneic bone marrow transplant recipients at high risk of developing CMV infections.
Bone marrow transplantation 1994;13(6):783-8.
-
1994: Bacigalupo A; van Lint M T; Tedone E; Moro F; Sanna M A; Longren M; Trespi G; Frassoni F; Occhini D; Gualandi F
Early treatment of CMV infections in allogeneic bone marrow transplant recipients with foscarnet or ganciclovir.
Bone marrow transplantation 1994;13(6):753-8.
-
1994: Fagioli F; Bacigalupo A; Frassoni F; Van Lint M T; Occhini D; Gualandi F; Lamparelli T; Clavio M; Vitale V; Sogno G
Allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission: the effect of FAB classification and GVHD prophylaxis.
Bone marrow transplantation 1994;13(3):247-52.
-
1993: Bacigalupo A; Gualandi F; Van Lint M T; Sessarego M; Frassoni F; Occhini D; Lamparelli T; Oneto R; Vitale V; Corvo R
Multivariate analysis of risk factors for survival and relapse in chronic granulocytic leukemia following allogeneic marrow transplantation: impact of disease related variables (Sokal score).
Bone marrow transplantation 1993;12(5):443-8.
-
1993: Bacigalupo A; Piaggio G; Podestá M; Van Lint M T; Valbonesi M; Lercari G; Mori P G; Pasino M; Franchini E; Rivabella L
Collection of peripheral blood hematopoietic progenitors (PBHP) from patients with severe aplastic anemia (SAA) after prolonged administration of granulocyte colony-stimulating factor.
Blood 1993;82(5):1410-4.
-
1993: Bacigalupo A; Chaple M; Hows J; Van Lint M T; McCann S; Milligan D; Chessells J; Goldstone A H; Ottolander J; van't Veer E T
Treatment of aplastic anaemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: a randomized trial from the EBMT SAA working party.
British journal of haematology 1993;83(1):145-51.
-
1992: Bacigalupo A; Tedone E; Sanna M A; Moro F; Van Lint M T; Grazi G; Balestreri M; Frassoni F; Occhini D; Gualandi F
CMV infections following allogeneic BMT: risk factors, early treatment and correlation with transplant related mortality.
Haematologica 1992;77(6):507-13.
-
1992: Bacigalupo A; Tong J; Podesta M; Piaggio G; Figari O; Colombo P; Sogno G; Tedone E; Moro F; Van Lint M T
Bone marrow harvest for marrow transplantation: effect of multiple small (2 ml) or large (20 ml) aspirates.
Bone marrow transplantation 1992;9(6):467-70.
-
1992: McCann S R; Lawler M; Humphries P; Bacigalupo A; Podesta M; Frassoni F; Van Lint M T; Marmont A
Recurrence of Philadelphia chromosome-positive leukemia in donor cells after marrow transplantation for chronic granulocytic leukemia: confirmation by microsatellite studies.
Blood 1992;79(10):2803-5.
-
1991: Bacigalupo A; Van Lint M T; Occhini D; Gualandi F; Lamparelli T; Sogno G; Tedone E; Frassoni F; Tong J; Marmont A M
Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia.
Blood 1991;77(7):1423-8.
-
1991: Locasciulli A; van' t Veer L; Hows J; Van Lint M T; Gluckman E; Nissen C; McCann S; Vossen J; Schrezenmeier A; Hinterberger W
Bone marrow transplantation (BMT) in children with severe aplastic anemia (SAA) from donors other than HLA identical siblings. EBMT Working Party on Severe Aplastic Anemia.
Bone marrow transplantation 1991;7 Suppl 3():90-1.
-
1991: Bacigalupo A; Van Lint M T; Frassoni F; Occhini D; Gualandi F; Lamparelli T; Sogno G; Tedone E; Frassoni F; Tong J
Factors influencing remission post-BMT in patients with acute and chronic leukemia prepared with cyclophosphamide and total body irradiation (TBI).
Bone marrow transplantation 1991;7 Suppl 3():62-3.
-
1990: Bacigalupo A; van Lint M T; Frassoni F; Occhini D; Gualandi F; Lamparelli T; Marmont A; Comelli A; Dini G; Massino L
Allogeneic bone marrow transplantation versus chemotherapy for childhood acute lymphoblastic leukemia in second remission: an update.
Bone marrow transplantation 1990;6(5):353-4.
-
1990: Bacigalupo A; Maiolino A; Van Lint M T; Occhini D; Gualandi F; Clavio M; Lamparelli T; Tong J; Marmon A M
Cyclosporin A and chronic graft versus host disease.
Bone marrow transplantation 1990;6(5):341-4.
-
1990: Locasciulli A; van't Veer L; Bacigalupo A; Hows J; Van Lint M T; Gluckman E; Nissen C; McCann S; Vossen J; Schrezenmeier A
Treatment with marrow transplantation or immunosuppression of childhood acquired severe aplastic anemia: a report from the EBMT SAA Working Party.
Bone marrow transplantation 1990;6(3):211-7.
-
1989: Bacigalupo A; Van Lint M T; Frassoni F; Occhini D; Piaggio G; Figari O; Gualandi F; Marmont T I
Bone marrow transplantation for severe aplastic anaemia (SAA): the Genova experience.
Bone marrow transplantation 1989;4 Suppl 4():121-2.
-
1989: Frassoni F; Scarpati D; Bacigalupo A; Vitale V; Corvo R; Miceli S; Gualandi F; Occhini D; Clavio M; van Lint M T
The effect of total body irradiation dose and chronic graft-versus-host disease on leukaemic relapse after allogeneic bone marrow transplantation.
British journal of haematology 1989;73(2):211-6.
-
1989: Bacigalupo A; Frassoni F; Van Lint M T; Occhini D; Gualandi F; Lamparelli T; Vitale V; Scarpati D; Clavio M; Marmont A M
[Allogeneic bone marrow transplantation in acute and chronic myeloid leukemia: role of conditioning and of graft-versus-host disease in the long-term maintenance of remission]
Haematologica 1989;74(5 Suppl):425-32.
-
1989: Bacigalupo A; Van Lint M T; Frassoni F; Vitale V; Scarpati D; Occhini D; Gualandi F; Clavio M; Maiolino A; Marmont A M
Bone marrow transplantation (BMT) for acute non lymphoid leukemia (ANLL) in first remission: an update.
Haematologica 1989;74(4):418-9.
-
1988: Bacigalupo A; Hows J; Gordon-Smith E C; Gluckman E; Van Lint M T; Congiu M; James D C; Barrett A J; Gmur J; De Planque M M
Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings: a report of the BMT Working Party.
Bone marrow transplantation 1988;3(6):531-5.
-
1988: Bacigalupo A; Hows J; Gluckman E; Nissen C; Marsh J; Van Lint M T; Congiu M; De Planque M M; Ernst P; McCann S
Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party.
British journal of haematology 1988;70(2):177-82.
-
1988: Bacigalupo A; Van Lint M T; Occhini D; Margiocco M; Ferrari G; Pittaluga P A; Frassoni F; Peralvo J; Lercari G; Carubia F
ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation.
Transplantation 1988;45(6):1091-4.
-
1987: Peralvo J; Bacigalupo A; Pittaluga P A; Occhini D; Van Lint M T; Frassoni F; Nardelli E; Transino A; Pantarotto M; Marmout A M
Poor graft function associated with graft-versus-host disease after allogeneic marrow transplantation.
Bone marrow transplantation 1987;2(3):279-85.
-
1987: Bacigalupo A; Van Lint M T; Peralvo J; Osvaldo Figari G P; Marmont A M
Ranitidine and hematologic recovery in aplastic anemia.
Haematologica 1987;72(4):378-9.
-
1987: Bacigalupo A; Van Lint M T; Frassoni F; Occhini D; Pittaluga P A; Piaggio G; Figari O; Marmont A M
Clinical problems associated with T cell depletion for bone marrow transplantation.
Annals of the New York Academy of Sciences 1987;511():459-63.
-
1987: Gallamini A; Buffa F; Bacigalupo A; Van Lint M T; Peralvo J; Pittaluga P A; Occhini D; Marmont A M
Allogeneic bone marrow transplantation in multiple myeloma.
Acta haematologica 1987;77(2):111-4.
-
1986: Bacigalupo A; Van Lint M T; Frassoni F; Occhini D; Pittaluga P A; Comelli A; Dini G; Massimo L; Marmont A M
Allogeneic bone marrow transplantation versus chemotherapy for childhood acute lymphoblastic leukaemia in second remission.
Bone marrow transplantation 1986;1(1):75-80.
-
1985: Bacigalupo A; Frassoni F; van Lint M T; Raffo M R; Vitale V; Corbetta G; Chierichetti S; Marmont A M
Cyclosporin A in marrow transplantation for leukemia and aplastic anemia.
Experimental hematology 1985;13(4):244-8.
-
1985: Bacigalupo A; Frassoni F; Podesta' M; Piaggio G; Van Lint M T; Repetto M; Marmont A M
Cyclosporin A (CyA) does not enhance CFU-c growth in patients with severe aplastic anaemia.
Scandinavian journal of haematology 1985;34(2):133-6.
-
1985: Marmont A M; Cerri R; Lercari G; Van Lint M T; Bacigalupo A; Risso M
Positive direct antiglobulin tests and heteroimmune hemolysis in patients with severe aplastic anemia and pure red cell anemia treated with antilymphocytic globulin.
Acta haematologica 1985;74(1):14-8.
-
1984: Bacigalupo A; Van Lint M T; Frassoni F; Clavio M; Soro O; Grazi G; Melioli G; Pedullà D; Sbaffi A; Acornero L
Infections in a bone marrow transplant unit: analysis of 57 patients.
Haematologica 1984;69(1):41-52.
-
1984: Marmont A M; Bacigalupo A; Van Lint M T; Frassoni F; Podesta M; Reali G; Piaggio G
Treatment of severe aplastic anemia with high-dose methylprednisolone and antilymphocyte globulin.
Progress in clinical and biological research 1984;148():271-87.
-
1984: Bacigalupo A; Podestá M; Frassoni F; Piaggio G; Raffo M R; Repetto M; Van Lint M T; Marmont A M
T-derived colony-inhibiting activity (Td/CIA) in aplastic anemia (SAA) and in normal donors.
Progress in clinical and biological research 1984;148():173-83.
-
1983: Vitale V; Bacigalupo A; Van Lint M T; Frassoni F; Ricci G; Siracusa G; Marziano G; Vitali M L; Scielzo G; Tomassini A
Fractionated total body irradiation in marrow transplantation for leukaemia.
British journal of haematology 1983;55(3):547-54.
-
1983: Marmont A M; Bacigalupo A; Van Lint M T; Frassoni F; Risso M; Cerri R; Rossi E; Damasio E E; Santini G; Carella M
Treatment of severe aplastic anemia with sequential immunosuppression.
Experimental hematology 1983;11(9):856-65.
-
1983: Marmont A M; Bacigalupo A; Van Lint M T; Frassoni F; Podesta' M; Bistolfi F; Vitale V; Ricci G; Siracusa G; Marziano G; Scielzo G; Tomassini E; Reali G; Adami R; Strada P; Barbanti M; Solda' A; Adami G F; Dagna Bricarelli F; Veneziano G; Grazi G; Soro O; Melioli G; Pedulla' D; Lercari G; Carella A; Damasio E; Piaggio G; Raffo M R; Risso M; Cerri R; Santini G; Vimercati R; Rossi E; Giordano D; Repetto M; Siccardi M; Queirolo M A; Avanzi G
Bone marrow transplantation for leukemia in Genova.
Haematologica 1983;68(3):351-67.
-
1983: Bacigalupo A; van Lint M T; Frassoni F; Podesta' M; Veneziano G; Avanzi G; Vitale V; Marmont A M
High dose bolus methylprednisolone for the treatment of acute graft versus host disease.
Blut 1983;46(3):125-32.
-
1983: Van Lint M T; Bacigalupo A; Frassoni F; Podestà M; Soro O; Grazi G; Marmont A
Ketoconazole versus mepartricin for the prevention of Candida infections in the immunocompromised host.
Haematologica 1983;68(2):226-32.
-
1983: Vitale V; Scielzo G; Ricci G; Bacigalupo A; Tomassini E; Marziano C; Siragusa A; Van Lint M T; Bistolfi F
[Total body irradiation in the preparation of leukemic patients for bone marrow transplantation]
La Radiologia medica 1983;69(1-2):29-36.
-
1983: Podestà M; Bacigalupo A; Frassoni F; Raffo M R; Piaggio G; Repetto M; Van Lint M T; Marmont A
Generation of CFU-c suppressor T cells. VI. Effect of cyclosporin A.
Acta haematologica 1983;70(3):163-9.
-
1982: Frassoni F; Bacigalupo A; Podestá M; Van Lint M T; Piaggio G; Marmont A
Generation of CFU-C suppressor T cells in vitro. III. Failure of mitogen-primed T cells from patients with chronic granulocytic leukemia to inhibit the growth of normal CFU-C.
Blood 1982;60(6):1447-52.
-
1982: Bacigalupo A; Podesta' M; Frassoni F; Piaggio G; Van Lint M T; Raffo M R; Repetto M; Marmont A
Generation of CFU-C suppressor T cells in vitro. V. A multistep process.
British journal of haematology 1982;52(3):421-7.
-
1982: Podesta M; Frassoni F; Van Lint M T; Piaggio G; Giordano D; Cerri R; Marmont A; Bacigalupo A
Generation of CFU-c suppressor T cells in vitro. IV. effect of time on the inhibitory activity of mitogen-primed normal T lymphocytes.
Thymus 1982;4(4):233-42.
-
1982: Frassoni F; Podesta M; van Lint M T; Marmont A; Rossi E; Vimercati R; Bacigalupo A
GM-CFC growth in chronic granulocytic leukaemia is not affected by a soluble inhibitor released by aplastic anaemia T-cells or mitogen-primed normal T-lymphocytes.
British journal of haematology 1982;50(4):647-53.
-
1982: Podesta M; Frassoni F; van Lint M T; Piaggio G; Marmont A; Bacigalupo A
Generation of CFUC suppressor T cells in vitro. II. Effect of PHA, PWM, and Con-A on bone marrow and peripheral blood lymphocytes from healthy donors.
Experimental hematology 1982;10(3):256-62.
-
1981: Bacigalupo A; Mingari M C; Moretta L; Podesta' M; Van Lint M T; Piaggio G; Raffo M R; Marmont A
Imbalance of T-cell subpopulations and defective pokeweed mitogen-induced B-cell differentiation after bone marrow transplantation in man.
Clinical immunology and immunopathology 1981;20(2):137-45.
-
1981: Carella A M; Nicolino M; Santini G; Occhini D; Damasio E E; Rossi E; Giordano D; Vimercati R; Risso M; Bacigalupo A; Carubia F; Spriano M; Van Lint M T; Taroppio T; Pittaluga A; Marmont A M
[Induction and consolidation combination chemotherapy with 8 drugs (L-10 protocol) for acute lymphoblastic leukemia (author's transl)]
Haematologica 1981;66(3):311-26.
-
1981: Damasio E; Lambertenghi Deliliers G; Zanon P; Vimercati R; Occhini D; Rossi E; Santini G; Giordano D; Carella M; Cerri R; Van Lint M T; Risso M; Spriano M; Durando A; Piaggio G; Raffo M R; Siccardi M; Grassia L; Podestà M; Banchi L; Benacchio L; Marmont A
[Hairy cell leukemia. Clinical, hematological, immunological and ultrastructural observations on 6 cases. Review of literature]
Recenti progressi in medicina 1981;70(3):217-58.
-
1981: Bacigalupo A; Podesta' M; Van Lint M T; Vimercati R; Cerri R; Rossi E; Risso M; Carella A; Santini G; Damasio E; Giordano D; Marmont A M
Severe aplastic anaemia: correlation of in vitro test with clinical response to immunosuppression in 20 patients.
British journal of haematology 1981;47(3):423-32.
-
1981: Bacigalupo A; Avanzi G; Van Lint M T; Reali G; Solda' A; Adami R; Strada P; Barbanti M; Podesta' M; Marmont A
Platelet support in patients undergoing bone marrow transplantation.
Haematologica 1981;66(1):80-90.
-
1980: Bacigalupo A; Podesta' M; Raffo M R; Piaggio G; Van Lint M T; Vimercati R; Spriano V M; Risso M; Marmont A M
Lack of in vitro colony (CFUC) formation and myelosuppressive activity in patients with severe aplastic anemia after autologous hematologic reconstitution.
Experimental hematology 1980;8(6):795-801.
-
1980: Bacigalupo A; Avanzi G; Strada P; Adami R; Reali G; Barbanti M; Soldà A; Van Lint M T; Risso M; Rossi E; Cerri R; Vimercati R; Taroppio T; Spriano M; Brema F; Vitale V; Marmont A
Major ABO incompatible bone marrow transplantation.
Haematologica 1980;65(2):211-21.
-
1980: Bacigalupo A; Mingari M C; Moretta L; van Lint M T; Piaggio G; Raffo M R; Podesta M; Marmont A M
T cell subpopulations after allogeneic bone marrow transplantation.
Haematology and blood transfusion 1980;25():135-40.
Sign-in to see more